These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1708319)

  • 1. Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
    Dis Markers; 1990; 8(4):226-7. PubMed ID: 1708319
    [No Abstract]   [Full Text] [Related]  

  • 2. High frequency of antibodies against recombinant HIV-2 Nef protein in HIV-2-positive and HIV-negative sera.
    Mayer J; Kienzle N; Ulrich R; Hunsmann G; Mueller-Lantzsch N
    AIDS; 1992 May; 6(5):519-20. PubMed ID: 1616664
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
    Ranki A; Järvinen K; Valle SL; Nurmilaakso P; Krohn K
    J Acquir Immune Defic Syndr (1988); 1990; 3(4):348-55. PubMed ID: 2179525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
    Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current approaches to vaccination against human immunodeficiency viruses.
    Gluckman JC; Yagello M; Bahraoui E; Girard M
    Allergol Immunopathol (Madr); 1991; 19(1):11-3. PubMed ID: 1719790
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of anti-p27nef antibody detection in HIV-seronegative high-risk people.
    Gluckman JC; Fretz-Foucault C; Rouzioux C; Perret P; Lopez O; Bucquet D; Bahraoui E
    AIDS; 1989 Dec; 3(12):855-6. PubMed ID: 2517205
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccine-induced HIV seropositivity: a problem on the rise.
    Van Braeckel E; Koutsoukos M; Bourguignon P; Clement F; McNally L; Leroux-Roels G
    J Clin Virol; 2011 Apr; 50(4):334-7. PubMed ID: 21300566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.
    Harrer E; Bäuerle M; Ferstl B; Chaplin P; Petzold B; Mateo L; Handley A; Tzatzaris M; Vollmar J; Bergmann S; Rittmaier M; Eismann K; Müller S; Kalden JR; Spriewald B; Willbold D; Harrer T
    Antivir Ther; 2005; 10(2):285-300. PubMed ID: 15865223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to human immunodeficiency virus type 1 in exposed but uninfected individuals: protection or chance?
    Looney DJ
    J Clin Invest; 1994 Mar; 93(3):920. PubMed ID: 8132777
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of human immunodeficiency virus type 1 nef gene product expressed by a recombinant baculovirus.
    Matsuura Y; Maekawa M; Hattori S; Ikegami N; Hayashi A; Yamazaki S; Morita C; Takebe Y
    Virology; 1991 Oct; 184(2):580-6. PubMed ID: 1909480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice.
    Ferko B; Stasakova J; Sereinig S; Romanova J; Katinger D; Niebler B; Katinger H; Egorov A
    J Virol; 2001 Oct; 75(19):8899-908. PubMed ID: 11533153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to the nef protein and to nef peptides in HIV-1-infected seronegative individuals.
    Ameisen JC; Guy B; Chamaret S; Loche M; Mouton Y; Neyrinck JL; Khalife J; Leprevost C; Beaucaire G; Boutillon C
    AIDS Res Hum Retroviruses; 1989 Jun; 5(3):279-91. PubMed ID: 2786420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic epitopes of NEF proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV infection.
    Gombert FO; Blecha W; Tähtinen M; Ranki A; Pfeifer S; Tröger W; Braun R; Müller-Lantzsch N; Jung G; Rübsamen-Waigmann H
    Virology; 1990 Jun; 176(2):458-66. PubMed ID: 1693246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I infected individuals.
    Dis Markers; 1990; 8(3):165-6. PubMed ID: 1703062
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents.
    Coplan PM; Gupta SB; Dubey SA; Pitisuttithum P; Nikas A; Mbewe B; Vardas E; Schechter M; Kallas EG; Freed DC; Fu TM; Mast CT; Puthavathana P; Kublin J; Brown Collins K; Chisi J; Pendame R; Thaler SJ; Gray G; Mcintyre J; Straus WL; Condra JH; Mehrotra DV; Guess HA; Emini EA; Shiver JW
    J Infect Dis; 2005 May; 191(9):1427-34. PubMed ID: 15809900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the HIV-1 Nef protein in the baculovirus system: investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef.
    Kienzle N; Enders M; Buck M; Siakkou H; Jahn S; Petzold G; Schneweis KE; Bachmann M; Müller WE; Müller-Lantzsch N
    Arch Virol; 1992; 126(1-4):293-301. PubMed ID: 1524496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of a nef-specific monoclonal antibody by the use of a synthetic peptide.
    De Santis R; Anastasi AM; Marcolini S; Valesini G; Pezzella M; Vonesch N; Sturchio E; Mele A
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):315-21. PubMed ID: 2064828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.
    Hadida F; Haas G; Zimmermann N; Hosmalin A; Spohn R; Samri A; Jung G; Debre P; Autran B
    J Immunol; 1995 Apr; 154(8):4174-86. PubMed ID: 7535824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to HIV-1 nef(p27): prevalence, significance, and relationship to seroconversion.
    Cheingsong-Popov R; Panagiotidi C; Ali M; Bowcock S; Watkins P; Aronstam A; Wassef M; Weber J
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1099-105. PubMed ID: 2265027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.